US Patent Issued to GENEVANT SCIENCES on July 7 for "Cationic lipids for lipid nanoparticle delivery of therapeutics to hepatic stellate cells" (Canadian Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,963, issued on July 7, was assigned to GENEVANT SCIENCES GMBH (Basel, Switzerland).

"Cationic lipids for lipid nanoparticle delivery of therapeutics to hepatic stellate cells" was invented by James Heyes (Vancouver, Canada), Kieu Mong Lam (Burnaby, Canada), Richard J. Holland (Vancouver, Canada) and Wenxuan Zhang (Burnaby, Canada).

According to the abstract* released by the U.S. Patent & Trademark Office: "Certain embodiments of the invention provide lipids useful for preparing lipid nanoparticles for delivering therapeutic agents to, e.g., hepatic stellate cells."

The patent was filed on Feb. 11, 2021, under Application No. 17/797,760.

*For further information, including images...